SCHEMBL3764612

SCHEMBL3764612

CC(C)(C)OC(=O)N1CCN(c2nc(-c3ccccc3)co2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 2/20 0.56
▸ SKP1 P63208 2/20 0.56
▸ SKP2 Q13309 2/20 0.56
▸ ABCB1 P08183 2/20 0.55
▸ ABCG2 Q9UNQ0 1/20 0.55
▸ GBA1 P04062 2/20 0.49
▸ GPR119 Q8TDV5 2/20 0.48
▸ KIT P10721 1/20 0.48
▸ ACHE P22303 1/20 0.47
▸ JAK2 O60674 1/20 0.46
▸ JAK3 P52333 1/20 0.46
▸ SMARCA2 P51531 1/20 0.46
▸ SMARCA4 P51532 1/20 0.46
▸ PBRM1 Q86U86 1/20 0.46
▸ PTPN11 Q06124 1/20 0.45
▸ ADORA2A P29274 1/20 0.45
▸ ITGB2 P05107 1/20 0.45
▸ ICAM1 P05362 1/20 0.45
▸ ITGAL P20701 1/20 0.45
▸ BACE1 P56817 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25419563 0.82 CKS1B (0.49) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL26146349 0.81 ACHE (0.52) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL17373792 0.81 CKS1B (0.46) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL14990872 0.80 CKS1B (0.46) CKS1BSKP1SKP2GPR119ACHE
SCHEMBL26146347 0.80 CKS1B (0.47) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL17100788 0.79 MAPT (0.57) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL3275117 0.79 CKS1B (0.65) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL26094150 0.77 CKS1B (0.43) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL3274585 0.77 ACHE (0.66) CKS1BSKP1SKP2ABCB1ABCG2
SCHEMBL31197670 0.77 CKS1B (0.50) CKS1BSKP1SKP2ABCB1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 — — US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 — — US disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 CKS1B 2817/4885SKP1 675/4885SKP2 1732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback